Literature DB >> 23859260

COX-2 inhibitory activity of homoisoflavanones and xanthones from the bulbs of the Southern African Ledebouria socialis and Ledebouria ovatifolia (Hyacinthaceae: Hyacinthoideae).

Catherine P Waller1, Alfred E Thumser, Moses K Langat, Neil R Crouch, Dulcie A Mulholland.   

Abstract

The bulbs of Ledebouria socialis (Hyacinthaceae) yielded the benzocyclobutene homoisoflavonoid, (R)-2',5-dihydroxy-3',4',7-trimethoxyspiro{2H-1-benzopyran-3-(4H)-9-bicyclo[4.2.0]octa[1,3,5]triene}-4-one, socialinone (1). Ledebouria ovatifolia yielded (2ε,3R)-2,5-dihydroxy-7-methoxyspiro[2H-1-benzopyran-3(4H), 5'(6'H)-cyclobuta[f][1,3]benzodioxol]-4-one (2) and the homoisoflavanone, (E)-3-(3',4'-dihydroxybenzylidene)-5,7-dihydroxychroman-4-one, ovatifolionone (5), the dihydrochalcone, 4,4'-dihydroxy-2',6'-dimethoxydihydrochalcone (3), and xanthone, 1,6-dihydroxy-2,3,5-trimethoxy-8-methyl-9H-xanthen-9-one (4) along with 21 known compounds. Structures were determined using spectroscopic techniques. The anti-inflammatory activities of the homoisoflavonoids and xanthones isolated were evaluated against cyclooxygenase-1 and -2 isoenzymes. (R)-3-(3',4'-Dihydroxybenzyl)-7-hydroxy-5-methoxychroman-4-one (7), (E)-3-(3',4'-dihydroxybenzylidene)-7-hydroxy-5-methoxychroman-4-one (10), 1,3,6-trihydroxy-2-methoxy-8-methylxanthen-9-one (6) and ovatifolionone acetate (5Ac) exhibited significant activity against cyclooxygenase-2 at <10μM.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anti-inflammatory; Cyclooxygenase activity; Homoisoflavanone; Hyacinthaceae; Ledebouria ovatifolia; Ledebouria socialis; Ovatifolionone; Socialinone; Xanthone

Mesh:

Substances:

Year:  2013        PMID: 23859260     DOI: 10.1016/j.phytochem.2013.06.024

Source DB:  PubMed          Journal:  Phytochemistry        ISSN: 0031-9422            Impact factor:   4.072


  8 in total

1.  Highly selective inhibition of IMPDH2 provides the basis of antineuroinflammation therapy.

Authors:  Li-Xi Liao; Xiao-Min Song; Li-Chao Wang; Hai-Ning Lv; Jin-Feng Chen; Dan Liu; Ge Fu; Ming-Bo Zhao; Yong Jiang; Ke-Wu Zeng; Peng-Fei Tu
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-03       Impact factor: 11.205

2.  2,3-Diarylxanthones as Potential Inhibitors of Arachidonic Acid Metabolic Pathways.

Authors:  Clementina M M Santos; Daniela Ribeiro; Artur M S Silva; Eduarda Fernandes
Journal:  Inflammation       Date:  2017-06       Impact factor: 4.092

3.  The Antiangiogenic Activity of Naturally Occurring and Synthetic Homoisoflavonoids from the Hyacinthaceae ( sensu APGII).

Authors:  Sianne Schwikkard; Hannah Whitmore; Kamakshi Sishtla; Rania S Sulaiman; Trupti Shetty; Halesha D Basavarajappa; Catherine Waller; Alaa Alqahtani; Lennart Frankemoelle; Andy Chapman; Neil Crouch; Wolfgang Wetschnig; Walter Knirsch; Jacky Andriantiana; Eduard Mas-Claret; Moses K Langat; Dulcie Mulholland; Timothy W Corson
Journal:  J Nat Prod       Date:  2019-04-05       Impact factor: 4.050

4.  5-Alkylresorcinol Derivatives from the Bryozoan Schizomavella mamillata: Isolation, Synthesis, and Antioxidant Activity.

Authors:  María J Ortega; Juan J Pantoja; Carolina de Los Reyes; Eva Zubía
Journal:  Mar Drugs       Date:  2017-11-02       Impact factor: 5.118

Review 5.  Recent development on COX-2 inhibitors as promising anti-inflammatory agents: The past 10 years.

Authors:  Zhiran Ju; Menglan Li; Junde Xu; Daniel C Howell; Zhiyun Li; Fen-Er Chen
Journal:  Acta Pharm Sin B       Date:  2022-01-11       Impact factor: 14.903

Review 6.  Chemical and Biological Research on Herbal Medicines Rich in Xanthones.

Authors:  Jingya Ruan; Chang Zheng; Yanxia Liu; Lu Qu; Haiyang Yu; Lifeng Han; Yi Zhang; Tao Wang
Journal:  Molecules       Date:  2017-10-11       Impact factor: 4.411

Review 7.  A Comprehensive Review on Chemotaxonomic and Phytochemical Aspects of Homoisoflavonoids, as Rare Flavonoid Derivatives.

Authors:  Javad Mottaghipisheh; Hermann Stuppner
Journal:  Int J Mol Sci       Date:  2021-03-08       Impact factor: 5.923

Review 8.  Chromanone-A Prerogative Therapeutic Scaffold: An Overview.

Authors:  Sonia Kamboj; Randhir Singh
Journal:  Arab J Sci Eng       Date:  2021-06-30       Impact factor: 2.807

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.